MeritValue

Glucotrack, Inc.

GCTKdata completeness 75%23 fiscal years on file

Data notes: no data for concept 'totalDebt'; no data for concept 'incomeTaxExpense'

The thesis, from the filings

Glucotrack, Inc. earns about -337% on equity, and has bought back 96% of its shares over 5 years. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.

i. The business — what you’d actually own
FigureFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue—————
Net income−$4.07M1−$4.44M2−$7.1M3−$22.6M4−$19.4M4
Operating cash flow−$3.77M5−$3.73M6−$6.56M7−$12.5M8−$15.2M8
Capital expenditure$5,0009$1,00010—$104,00011$96,00011
Free cash flow (derived)−$3.77M5−$3.73M6—−$12.6M8−$15.3M8
Total debt—————
Cash & equivalents$6.06M12$2.31M13$4.49M14$5.62M15$7.38M15
Diluted shares15.5M15.5M207,6035,503621,094

Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).

ii. Your slice — ownership made literal
If you owned
shares
Net assets behind them
$45.53
your share of equity
Profit it earned you last year
−$312.16
Free cash flow it threw off
−$246.92
Debt you’d be carrying
—

10 shares is a claim on $45.53 of net worth that earned you −$312.16 and generated −$246.92 of cash last year.

iii. Is this a good business?
Moat signal · return on equity
-337% avg · 5y
FY21 -79%FY22 -361%FY23 -222%FY24 —FY25 -686%

It earned an average -337% on equity over 5 years. Compare that to what it costs to fund the business.

seeing a moat in the numbers →
Management signal · capital allocation
−96% shares · 5y

Share count is down 96% over 5 years — management has been buying back stock, quietly handing owners a bigger slice.

reading capital allocation →

Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.

iv. What it’s worth — engine v0.1.0
DCF · Growth Exit 10Y
not applicable
3y-median FCF non-positive — growth-exit DCF not applicable (see EPV)
DCF · Growth Exit 5Y
not applicable
3y-median FCF non-positive — growth-exit DCF not applicable (see EPV)
Earnings Power Value
not applicable
normalized (5y-median) earnings non-positive — EPV undefined
Graham Number
$56.55
assumptions (1)
  • grahamMultiplier2250.0%

Different models answer different questions — which to trust when →

Sources — the receipts
  1. 10-K · period ending 2021-12-31 · accession 0001493152-23-010356 (NetIncomeLoss)
  2. 10-K · period ending 2022-12-31 · accession 0001493152-24-011765 (NetIncomeLoss)
  3. 10-K · period ending 2023-12-31 · accession 0001641172-25-001861 (NetIncomeLoss)
  4. 10-K · period ending 2024-12-31 · accession 0001493152-26-013656 (NetIncomeLoss)
  5. 10-K · period ending 2021-12-31 · accession 0001493152-23-010356 (NetCashProvidedByUsedInOperatingActivities)
  6. 10-K · period ending 2022-12-31 · accession 0001493152-24-011765 (NetCashProvidedByUsedInOperatingActivities)
  7. 10-K · period ending 2023-12-31 · accession 0001641172-25-001861 (NetCashProvidedByUsedInOperatingActivities)
  8. 10-K · period ending 2024-12-31 · accession 0001493152-26-013656 (NetCashProvidedByUsedInOperatingActivities)
  9. 10-K · period ending 2021-12-31 · accession 0001493152-23-010356 (PaymentsToAcquirePropertyPlantAndEquipment)
  10. 10-K · period ending 2022-12-31 · accession 0001493152-24-011765 (PaymentsToAcquirePropertyPlantAndEquipment)
  11. 10-K · period ending 2024-12-31 · accession 0001493152-26-013656 (PaymentsToAcquirePropertyPlantAndEquipment)
  12. 10-K · period ending 2021-12-31 · accession 0001493152-23-010356 (CashAndCashEquivalentsAtCarryingValue)
  13. 10-K · period ending 2022-12-31 · accession 0001493152-24-011765 (CashAndCashEquivalentsAtCarryingValue)
  14. 10-K · period ending 2023-12-31 · accession 0001641172-25-001861 (CashAndCashEquivalentsAtCarryingValue)
  15. 10-K · period ending 2024-12-31 · accession 0001493152-26-013656 (CashAndCashEquivalentsAtCarryingValue)